Visceral leishmaniasis is caused by parasites of the genus Leishmania. Prevalent in developing countries, the disease is on the list of the world's most neglected diseases. Most cases (90%) in Latin America occur in Brazil, especially in the Northeast. The condition is treated mainly with pentavalent antimonials, an expensive and relatively inefficient drug known to induce resistance. In search of new antileishmanial drugs, much attention has been given to the medicinal properties of coumarin. In this study, coumarin was isolated from seeds of Amburana cearensis, purified and evaluated with regard to its ability to inhibit Leishmania chagasi promastigotes using the MTT test. The cell viability of macrophages treated with coumarin was also evaluated. The findings were submitted to one-way ANOVA for paired data, followed by the Bonferroni correction. The level of statistical significance was set at 5% (p < 0.05). Coumarin displayed low toxicity to macrophages in the MTT test (p > 0.05), but was toxic to Leishmania chagasi promastigotes (p < 0.05). Our results represent a contribution to the development of new drugs for the control or prophylaxis of visceral leishmaniasis.
Introduction
Leishmaniasis is a zoonotic disease caused by protozoa of the genus Leishmania. The parasite undergoes two development stages, one in the cells of the human mononuclear phagocyte system (amastigotes) and one in invertebrates (promastigotes) [1] . Classified as a "neglected disease", the condition is prevalent in socioeconomically challenged populations, especially in developing countries. About 12 million people are affected worldwide, with approximately 2 million new cases of the clinical form and 60,000 deaths each year [2] .
Visceral leishmaniasis (VL) is distributed worldwide. A Latin American form of the disease named American visceral leishmaniasis (AVL), or neotropical kala-azar, has been registered in at least 12 countries, with 90% of the reports coming from Brazil, especially from the Northeast [3] . Between 2006 and 2010, 18,168 new cases of VL were reported in Brazil, 47.1% of which from the Northeast [3] . In this country, Leishmania (L) infantum chagasi is the etiologic agent of visceral leishmaniasis [4] . Transmission occurs between humans and dogs bitten by infected sandflies of the genus Lutzomyia [5] .
Leishmaniasis is treated mainly with pentavalent antimonials, with a success rate of 26% -100%. However, the use of this medication is limited by serious side effects and parasite resistance [6] . Pentamidine or Amphotericin B is the choice of treatment in such cases [7] . Lately, much attention has been given to the search for phytotherapeutic compounds with potential antileishmanial activity [8] . In Brazil, about 80,000 species of plants with medicinal properties have been described. Coumarin is found in several of these [9] .
Amburana cearensis (Allemão) AC Smith is native to Northeastern Brazil but is currently widely distributed in South America, including regions of Argentina and Bolivia. Its bark and seeds have long been used to prepare homemade remedies for respiratory illnesses [10] .
The tree produces coumarin, a biologically active compound with antileishmanial properties [11] . In the present study, we evaluated the antileismananial activity of coumarin isolated from seeds of Amburana cearensis by testing for cell viability. The study is intended as a contribution to the development of new drugs for the control or prophylaxis of visceral leishmaniasis. 
Materials and Methods

Plant Material
Extraction and Chromatographic and Spectroscopic Identification
The collected seeds were fragmented and defatted with hexane. The dried seed powder was extracted overnight with 0.15 M NaCl under refrigeration at 8˚C. The extract was centrifuged at 10,000 ×g for 30 min and filtered in membrane with pore 0.45 μm.
Coumarin was extracted by partition from the total extract using chloroform.
An 80-mL aliquot was placed in a separatory funnel and homogenized with 90 mL of chloroform. The coumarin present in the organic phase was collected in a beaker with anhydrous sodium sulfate and then transferred to a tared becker.
The sample was covered with aluminum foil and left at room temperature overnight to dry the sample. The mass of coumarin was established by calculating the difference between the weight of the empty becker and the dry sample. Coumarin was submitted to thin-layer chromatography (TLC) for identification. To do so, a cellulose acetate plate with a sample of the extracted coumarin and a control sample of >99% pure standard coumarin (Sigma®) were analyzed in a chamber under UV light at 365 nm. The mobile phase consisted of chloroform and ethyl acetate (1:1) [12] .
The structure of the extracted compound was determined by analysis of nuclear magnetic resonance (NMR). The proton nuclear magnetic resonance ( 1 H NMR) and carbon-13 magnetic resonance ( Chemical shifts (δ) were expressed were expressed in parts per million (ppm) according to spectra. The proton spectra were referenced by peaks of the hydrogens belonging to the non-deuterated residual molecules of the solvent borne 
Cytotoxicity Assay
Macrophages (AMJ2C11) 
Statistical Analysis
The results of the in vitro tests were analyzed with the software Graph Pad Prism® 6.0. Mean values ± standard error of the mean (SEM) for each group were entered in a bar chart for comparison. Differences between treatments were analyzed with one-way ANOVA for paired data, followed by the Bonferroni correction. The level of statistical significance was set at 5% (p < 0.05).
Results
In this study, we evaluated the antileishmanial activity of coumarin isolated from seeds of Amburana cearensis. The crude extract yielded 0.0145 g of coumarin. Characterized by a pattern of intense fluorescence under UV light at 365 nm, the chromatographic profile of the sample was similar to that of pure standard coumarin. The isolated coumarin was identified as 1,2 benzopyrone by comparing the results of1H and 13C NMR. The Figure 2 shows the 1H NMR profile of the coumarin spectrum (300 MHz, CDCl 3 ) featured two multiplets at δ 7.51 and saturated lactone carbonyl, while the others were attached to sp2 carbons (δ 154.3 -116.9). The Table 1 demonstrates the results of the NMR scan allowed to deduce the molecular formula of coumarin (C 9 H 6 O 2 ) as being composed of a benzene ring and an α, β-unsaturated lactone ring (Table 1) .
In the cytotoxicity test, L. chagasi promastigotes were challenged in vitro with coumarin solutions at different concentrations (25, 50, 100, 200 and 500 μg/mL). Figure 4 shows that none of the coumarin concentrations displayed toxicity against macrophages (p > 0.05). All coumarin concentrations (25, 50, 100, 250 and 500 μg/mL) presented antileishmanial activity when compared to untreated control Leishmania (p < 0.05). As shown in Figure 5 , the antileishmanial activity of the coumarin solutions used in this study was not dose-dependent: the effect was statistically similar for all the concentrations tested (25, 50, 100, 250 and 500 μg/mL).
As shown in Figure 5 , the antileishmanial activity of the coumarin solutions used in this study was not dose-dependent: the effect was statistically similar for all the concentrations tested (25, 50, 100, 250 and 500 μg/mL).
Discussion
Known for its medicinal properties, coumarin (1,2 benzopyrone) has been isolated from many different plant species, including Amburana cearensis [14] . Extracts from the bark and seeds of this tree are used to treat disorders of the res- The bars represent mean values ± standard error of the mean (SEM) in each group. After subtracting the background absorbance (DMSO), the data were analyzed with ANOVA followed by the Bonferroni correction. C(-) = negative control. Spectral data for coumarin isolated from A. cearensis have been published before [16] . Based on ethanol extracts of seeds, [17] used NMR data to deduce the molecular formula of coumarin (C 9 H 6 O 2 ). This formula was confirmed in the present study by 1 H and 13 C NMR imaging.
The previously reported high level of activity of coumarim from seeds of A. cearensis against L. chagasi was confirmed in our experiments. [18] and [19] found coumarin extracted from the bark of A. cearensis to be efficient against Leishmania amazonensis, L. braziliensis and L. donovani at a concentration of 50 μg/mL. In addition, coumarin displayed antileishamanial action against L. chagasi at a concentration of 73 mg/mL [19] . To evaluate the antileishmanial activity of coumarin (-) mammea A/BB isolated from extracts of the leaves of Calophyllum brasiliensis, L. amazonensis promastigotes were challenged with 3.0 mg/mL (-) mammea A/BB for 72 hours. On electron microscopy, ultrastructural changes were observed, including binucleated cells, multiple vacuolation, intense exocytic activity in the flagellar pocket region and swollen mitochondria with concentric membranes in the mitochondrial matrix [20] .
The coumarin solutions tested in this study displayed no toxicity against macrophages in vitro. Macrophages are the target cells for Leishmania. They provide nutrients for amastigote development and favor the establishment of infection [21] . Phagocytosis occurs by adhesion of Leishmania promastigotes to macrophages by way of lectin-like ligands in the membrane. The induction of immune response involves the processing of antigenic material and the presentation to lymphocytes of this material on macrophage surfaces following phagocytosis and digestion [22] . Essentially, the parasite restricts the action of the immune system and inhibits the microbicidal action of the macrophages [23] .
The presence of the parasite leads to defects in macrophage-lymphocyte cooperation, making leishmaniasis a difficult-to-treat condition [24] .
In conclusion, leishmaniasis is a neglected disease, the treatment of which has remained unaltered for over 60 years despite serious side effects and the worldwide emergence of drug resistance. New strategies and therapies are needed to prevent and treat leishmaniasis. In vitro tests of leishmanicidal compounds extracted from plants like Amburana cearensis is a promising line of study towards the development of new antileishmanial drugs. The present study confirmed the antileishmanial activity of coumarin against L. chagasi promastigotes in vitro.
